Tempus Ai Cl A (TEM)

$52.32 +0.06 (0.11%)
Market Cap 9.30B
Revenue (ttm) 1.27B
Net Income (ttm) -245.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.27%
Debt to Equity Ratio 0.62
Volume 4,604,170
Avg Vol 5,520,328
Day's Range N/A - N/A
Shares Out 177.91M
Stochastic %K 35%
Beta 5.29
Analysts Sell
Price Target $78.21

Company Profile

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
StocksHunter1
StocksHunter1 Mar. 9 at 7:32 PM
$TEM who panic sold last night
0 · Reply
AcceleratorModel
AcceleratorModel Mar. 9 at 7:13 PM
$TEM added 50.40
0 · Reply
Alican1994
Alican1994 Mar. 9 at 6:42 PM
$TEM HC Wainwright & Co. Maintains Buy on Tempus AI, Raises Price Target to $95
0 · Reply
USMC223556
USMC223556 Mar. 9 at 6:07 PM
$TEM At least we are hanging tight . When the market is red we hold.
0 · Reply
JayBirdEvans
JayBirdEvans Mar. 9 at 5:57 PM
$TEM HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target from $89 to $95.
0 · Reply
RobotMumba100
RobotMumba100 Mar. 9 at 5:45 PM
$TEM free money here... this is the new $PLTR in pharma sector... 100$ end of the year! $MRK $AZN
0 · Reply
EmmanK
EmmanK Mar. 9 at 4:50 PM
$TEM just close at $52 today and all is forgiven
0 · Reply
googleismyson
googleismyson Mar. 9 at 3:32 PM
$TEM trash sir
0 · Reply
ZacksResearch
ZacksResearch Mar. 9 at 2:25 PM
$TEM just posted 83% revenue growth — but the real question is whether 2026 scales with it. The company is pushing growth by expanding diagnostics, MRD testing, and AI-driven clinical apps, though valuation concerns are starting to temper the outlook. ⚖️ Discover what could shape the growth story ahead 👉 https://www.zacks.com/stock/news/2880659/should-you-buy-hold-or-sell-tempus-ai-stock-heading-into-2026?cid=sm-stocktwits-2-2880659-teaser-36546&ADID=SYND_STOCKTWITS_TWEET_2_2880659_TEASER_36546
0 · Reply
TradersArc
TradersArc Mar. 9 at 2:10 PM
$TEM $LAES $USAR /
0 · Reply
Latest News on TEM
Tempus AI, Inc. (TEM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Mar 3, 2026, 3:12 PM EST - 6 days ago

Tempus AI, Inc. (TEM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

AI-Powered Tempus Inks New Multi-Year Merck Deal

Mar 3, 2026, 2:33 PM EST - 6 days ago

AI-Powered Tempus Inks New Multi-Year Merck Deal

MRK

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Mar 3, 2026, 8:30 AM EST - 6 days ago

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Tempus AI: Buy The Post-Earnings Dip

Feb 26, 2026, 10:16 AM EST - 11 days ago

Tempus AI: Buy The Post-Earnings Dip

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 26, 2026, 8:30 AM EST - 11 days ago

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Tempus AI: No AI Interruption Detected

Feb 25, 2026, 4:36 PM EST - 11 days ago

Tempus AI: No AI Interruption Detected

Tempus AI, Inc. (TEM) Q4 2025 Earnings Call Transcript

Feb 24, 2026, 11:57 PM EST - 12 days ago

Tempus AI, Inc. (TEM) Q4 2025 Earnings Call Transcript

Tempus AI Stock Drops Despite Q4 Earnings Beat: Details

Feb 24, 2026, 5:32 PM EST - 12 days ago

Tempus AI Stock Drops Despite Q4 Earnings Beat: Details

Tempus Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 4:01 PM EST - 12 days ago

Tempus Reports Fourth Quarter and Full Year 2025 Results

Is TEM Stock A Buy At $60?

Feb 19, 2026, 11:01 AM EST - 18 days ago

Is TEM Stock A Buy At $60?

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Feb 18, 2026, 8:30 AM EST - 19 days ago

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Feb 12, 2026, 4:05 PM EST - 24 days ago

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Feb 12, 2026, 4:05 PM EST - 24 days ago

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Feb 10, 2026, 8:30 AM EST - 27 days ago

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

Feb 4, 2026, 7:00 AM EST - 4 weeks ago

Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Feb 2, 2026, 7:00 AM EST - 5 weeks ago

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Jan 27, 2026, 8:30 AM EST - 5 weeks ago

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Jan 26, 2026, 11:14 AM EST - 6 weeks ago

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Tempus AI: Staying Bullish On Leading Healthcare AI Play

Jan 23, 2026, 9:44 AM EST - 6 weeks ago

Tempus AI: Staying Bullish On Leading Healthcare AI Play

Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference

Jan 22, 2026, 8:00 AM EST - 6 weeks ago

Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference

Tempus Announces the Launch of Paige Predict

Jan 21, 2026, 8:30 AM EST - 6 weeks ago

Tempus Announces the Launch of Paige Predict

Tempus AI, Inc. (TEM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:05 PM EST - 7 weeks ago

Tempus AI, Inc. (TEM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Jan 12, 2026, 8:30 AM EST - 2 months ago

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Here's why the Tempus AI stock may surge 47% soon

Jan 12, 2026, 8:00 AM EST - 2 months ago

Here's why the Tempus AI stock may surge 47% soon

Northwestern Medicine Selects Tempus to Expand Genomic Testing

Jan 12, 2026, 7:00 AM EST - 2 months ago

Northwestern Medicine Selects Tempus to Expand Genomic Testing

Stock Market Today: Dow Jones, S&P 500 Futures Tumble As DOJ Serves Federal Reserve—Vistra, Tempus AI, Alibaba In Focus

Jan 12, 2026, 5:33 AM EST - 2 months ago

Stock Market Today: Dow Jones, S&P 500 Futures Tumble As DOJ Serves Federal Reserve—Vistra, Tempus AI, Alibaba In Focus

BABA IVV SPXL SPY SSO UPRO VOO

Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Jan 11, 2026, 5:30 PM EST - 2 months ago

Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Jan 11, 2026, 5:00 PM EST - 2 months ago

Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Jan 8, 2026, 8:30 AM EST - 2 months ago

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care

Jan 8, 2026, 8:15 AM EST - 2 months ago

Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:30 AM EST - 2 months ago

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Tempus AI: A Healthcare Hyper-Growth Opportunity For The Risk Tolerant

Dec 18, 2025, 7:05 AM EST - 2 months ago

Tempus AI: A Healthcare Hyper-Growth Opportunity For The Risk Tolerant

Top 3 Health Care Stocks You'll Regret Missing This Quarter

Dec 18, 2025, 7:00 AM EST - 2 months ago

Top 3 Health Care Stocks You'll Regret Missing This Quarter

INSM LEGN

Tempus AI: Plenty Of Growth Catalysts Ahead, Grab It While It's Down

Dec 16, 2025, 10:13 AM EST - 2 months ago

Tempus AI: Plenty Of Growth Catalysts Ahead, Grab It While It's Down

Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium

Dec 9, 2025, 8:30 AM EST - 3 months ago

Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium

Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 3, 2025, 12:53 PM EST - 3 months ago

Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 8:30 AM EST - 3 months ago

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Tempus AI: Opportunity To Build Position

Nov 15, 2025, 10:00 AM EST - 4 months ago

Tempus AI: Opportunity To Build Position

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Nov 14, 2025, 8:30 AM EST - 4 months ago

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 13, 2025, 12:11 PM EST - 4 months ago

Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript

Tempus AI: Great Buying Opportunity On Recent Weakness

Nov 13, 2025, 9:59 AM EST - 4 months ago

Tempus AI: Great Buying Opportunity On Recent Weakness

Tempus AI: A Good Bet For The Future Of Health Care

Nov 12, 2025, 5:34 PM EST - 4 months ago

Tempus AI: A Good Bet For The Future Of Health Care

Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Nov 10, 2025, 9:55 PM EST - 4 months ago

Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says

Nov 5, 2025, 1:00 PM EST - 4 months ago

Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Nov 5, 2025, 8:30 AM EST - 4 months ago

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:06 PM EST - 4 months ago

Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript

Tempus Reports Third Quarter 2025 Results

Nov 4, 2025, 4:01 PM EST - 4 months ago

Tempus Reports Third Quarter 2025 Results

Tempus to Participate in the Stifel 2025 Healthcare Conference

Oct 28, 2025, 8:30 AM EDT - 4 months ago

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus to Report Third Quarter 2025 Financial Results on November 4

Oct 21, 2025, 8:30 AM EDT - 4 months ago

Tempus to Report Third Quarter 2025 Financial Results on November 4

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Oct 20, 2025, 9:00 AM EDT - 5 months ago

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

StocksHunter1
StocksHunter1 Mar. 9 at 7:32 PM
$TEM who panic sold last night
0 · Reply
AcceleratorModel
AcceleratorModel Mar. 9 at 7:13 PM
$TEM added 50.40
0 · Reply
Alican1994
Alican1994 Mar. 9 at 6:42 PM
$TEM HC Wainwright & Co. Maintains Buy on Tempus AI, Raises Price Target to $95
0 · Reply
USMC223556
USMC223556 Mar. 9 at 6:07 PM
$TEM At least we are hanging tight . When the market is red we hold.
0 · Reply
JayBirdEvans
JayBirdEvans Mar. 9 at 5:57 PM
$TEM HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target from $89 to $95.
0 · Reply
RobotMumba100
RobotMumba100 Mar. 9 at 5:45 PM
$TEM free money here... this is the new $PLTR in pharma sector... 100$ end of the year! $MRK $AZN
0 · Reply
EmmanK
EmmanK Mar. 9 at 4:50 PM
$TEM just close at $52 today and all is forgiven
0 · Reply
googleismyson
googleismyson Mar. 9 at 3:32 PM
$TEM trash sir
0 · Reply
ZacksResearch
ZacksResearch Mar. 9 at 2:25 PM
$TEM just posted 83% revenue growth — but the real question is whether 2026 scales with it. The company is pushing growth by expanding diagnostics, MRD testing, and AI-driven clinical apps, though valuation concerns are starting to temper the outlook. ⚖️ Discover what could shape the growth story ahead 👉 https://www.zacks.com/stock/news/2880659/should-you-buy-hold-or-sell-tempus-ai-stock-heading-into-2026?cid=sm-stocktwits-2-2880659-teaser-36546&ADID=SYND_STOCKTWITS_TWEET_2_2880659_TEASER_36546
0 · Reply
TradersArc
TradersArc Mar. 9 at 2:10 PM
$TEM $LAES $USAR /
0 · Reply
FXRST
FXRST Mar. 9 at 2:06 PM
$TEM I have a feeling we'll close in the green today. I hope so.😎🙏
0 · Reply
davidduong
davidduong Mar. 9 at 1:37 PM
$TEM Nothing juicy at this price to short. Even Short feels bored and risky.
0 · Reply
davidduong
davidduong Mar. 9 at 1:25 PM
$TEM Algo Sale = BUY a unicorn with a donkey cost. 👌😂
0 · Reply
ZacksResearch
ZacksResearch Mar. 9 at 1:25 PM
$TEM — Time to Book Profits? 🚨 Despite strong revenue growth and a booming precision medicine platform, Tempus AI trades at a premium with a Value Score of F and a 12-month forward P/S ratio of 5.64x, above the industry median. With geopolitical risks and cost pressures in play, the near-term risk-reward looks shaky. See why it might be time to pivot from this Zacks Rank #4 (Sell) stock 👉 https://www.zacks.com/stock/news/2880659/should-you-buy-hold-or-sell-tempus-ai-stock-heading-into-2026?cid=sm-stocktwits-2-2880659-body-36525&ADID=SYND_STOCKTWITS_TWEET_2_2880659_BODY_36525
0 · Reply
davidduong
davidduong Mar. 9 at 1:18 PM
$TEM Even Algo got shock and madly with the market.
0 · Reply
googleismyson
googleismyson Mar. 9 at 2:33 AM
$TEM betting on this kinda stock is a gambling just go to vegas.
0 · Reply
googleismyson
googleismyson Mar. 9 at 2:32 AM
$TEM No divergence, no sign of a golden cross, and trading below the 20-day EMA. With no upcoming catalysts or insider buying, what else should you guys look for? Fuk it lol move onto other one guys
0 · Reply
googleismyson
googleismyson Mar. 9 at 2:23 AM
$TEM this is why I dint give a f about algo. I only trade when there is a signal on the chart.
1 · Reply
davidduong
davidduong Mar. 9 at 12:54 AM
$TEM bottom at $50. Too undervalued at this price for a Unicorn. Algo sale = BUY
0 · Reply
googleismyson
googleismyson Mar. 9 at 12:25 AM
$TEM yeah cheer up bro.
1 · Reply
rimbo90
rimbo90 Mar. 7 at 6:50 PM
$TEM
0 · Reply